GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The product is expected to be launched in December 2023
The product is expected to be launched in FY25
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
The product is being launched in August 2023
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Subscribe To Our Newsletter & Stay Updated
